Fig. 6.
KDM6B is required for E2-mediated DMSC bone formation in vivo. Micro-CT images (a) and bone volume quantification (BV/TV) (b) of calvarial bone defects with scaffolds containing DMSC/shKDM6B and DMSC/Scrsh with and without E2. Scale bars, 1 mm. H&E staining images (c) and histomorphometric analysis for new bone area within calvarial bone defects (d) from mice with transplanted scaffolds seeded with DMSC/shKDM6B and DMSC/Scrsh with and without E2. Scale bars, 200 μm. e Immunostaining of KDM6B in bone tissue formed on scaffolds. Scale bars, 25 μm. Data are presented as the mean ± SEM (n = 4). For b and d, all the groups were compared by two-way ANOVA with a Bonferroni post hoc test. Asterisks were assigned to P values with statistical significance (*P < 0.05; **P < 0.01)